Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Opium-Induced Central Sleep Apnea
NCT02371473Phase 4Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2014
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetazolamide in central sleep apnea (CSA), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
acetazolamide
03
Conditions
central sleep apnea (CSA)
Beyond the preview
Go deeper on NCT02371473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02371473.